The presence of the homozygous deletion of the CDKN2A gene defines a group of patients with a worse prognosis [14], and it allows alone the classification of a tumor as “astrocytoma, grade 4” regardless of the histological features [4]. Here, CDKN2A is linked to astrocytoma (excluding glioblastoma).